UBS analyst Karl Keirstead lowered the firm’s price target on DocuSign (DOCU) to $80 from $85 and keeps a Neutral rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCU:
- DocuSign price target lowered to $85 from $93 at Baird
- DocuSign price target lowered to $86 from $92 at Morgan Stanley
- DocuSign’s Transitional Challenges and Strategic Investments Lead to Hold Rating
- DocuSign price target raised to $67 from $65 at Wells Fargo
- DocuSign’s Strategic Shift and Macroeconomic Challenges Lead to Hold Rating